Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clément Bailly

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Frontiers in Medicine|June 20, 2015
State-Of-The-Art and Recent Advances in Quantification for Therapeutic Follow-Up in Oncology Using PETThomas Carlier, Clément Bailly
Frontiers in Medicine|March 31, 2023
Editorial: Nuclear medicine in rheumatological diseases' therapy and diagnosisGiorgio Treglia, Clément Bailly
Clinical Kidney Journal|October 4, 2021
Value of FDG-PET/CT in monitoring cyst infections in patients with autosomal dominant polycystic renal diseaseCharles Ronsin, Clément Bailly, Paul Le Turnier, et al.
PET Clinics|August 26, 2025
The Importance of PET Quantification for Prognosis and Treatment Response MonitoringRonan Abgral, Clément Bailly, Ronald Boellaard, et al.
Current Oncology (Toronto, Ont.)|June 26, 2024
Combining Immune Checkpoint Inhibitors with Loco-Regional Treatments in Hepatocellular Carcinoma: Ready for Prime Time?Juliette Boilève, Valentine Guimas, Arthur David, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 20, 2016
ImmunoPET to help stratify patients for targeted therapies and to improve drug developmentFrançoise Kraeber-Bodere, Clément Bailly, Michel Chérel, et al.
International Journal of Cardiology|January 28, 2009
Cannabis induced acute coronary syndrome in a young femaleClément Bailly, Olivier Merceron, Nadjib Hammoudi, et al.
Haematologica|January 3, 2020
Reply to E. Laffon <i>et al</i>Clément Bailly, Thomas Carlier, Françoise Kraeber-Bodéré, et al.
EJNMMI Radiopharmacy and Chemistry|March 6, 2018
Pretargeting for imaging and therapy in oncological nuclear medicineClément Bailly, Caroline Bodet-Milin, Caroline Rousseau, et al.
Frontiers in Medicine|October 31, 2022
Immuno-PET: Design options and clinical proof-of-conceptAlexandre Lugat, Clément Bailly, Michel Chérel, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Frontiers in Medicine|June 20, 2015
State-Of-The-Art and Recent Advances in Quantification for Therapeutic Follow-Up in Oncology Using PETThomas Carlier, Clément Bailly
Frontiers in Medicine|March 31, 2023
Editorial: Nuclear medicine in rheumatological diseases' therapy and diagnosisGiorgio Treglia, Clément Bailly
Clinical Kidney Journal|October 4, 2021
Value of FDG-PET/CT in monitoring cyst infections in patients with autosomal dominant polycystic renal diseaseCharles Ronsin, Clément Bailly, Paul Le Turnier, et al.
PET Clinics|August 26, 2025
The Importance of PET Quantification for Prognosis and Treatment Response MonitoringRonan Abgral, Clément Bailly, Ronald Boellaard, et al.
Current Oncology (Toronto, Ont.)|June 26, 2024
Combining Immune Checkpoint Inhibitors with Loco-Regional Treatments in Hepatocellular Carcinoma: Ready for Prime Time?Juliette Boilève, Valentine Guimas, Arthur David, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 20, 2016
ImmunoPET to help stratify patients for targeted therapies and to improve drug developmentFrançoise Kraeber-Bodere, Clément Bailly, Michel Chérel, et al.
International Journal of Cardiology|January 28, 2009
Cannabis induced acute coronary syndrome in a young femaleClément Bailly, Olivier Merceron, Nadjib Hammoudi, et al.
Haematologica|January 3, 2020
Reply to E. Laffon <i>et al</i>Clément Bailly, Thomas Carlier, Françoise Kraeber-Bodéré, et al.
EJNMMI Radiopharmacy and Chemistry|March 6, 2018
Pretargeting for imaging and therapy in oncological nuclear medicineClément Bailly, Caroline Bodet-Milin, Caroline Rousseau, et al.
Frontiers in Medicine|October 31, 2022
Immuno-PET: Design options and clinical proof-of-conceptAlexandre Lugat, Clément Bailly, Michel Chérel, et al.
Pageof 6